Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Lung Surgery for Octogenarians

By HospiMedica staff writers
Posted on 21 Dec 2005
Elderly patients who have early stage non-small cell lung cancer (NSCLC) can benefit from a minimally invasive surgical procedure to remove part or all of a lung, according to a study conducted by thoracic surgeons at Cedars-Sinai Medical Center (Los Angeles, CA).

When non-small cell lung cancers, which account for about 75% of all lung cancers, are detected at an early, localized stage, surgical removal of the affected area often can prevent metastasis to other tissues and organs. More...


While open surgery continues to be used in about 95% of lobectomies nationally, elderly patients might not be good candidates for the physical demands of open chest surgery. Dr. Robert McKenna Jr., a thoracic surgeon and chief of thoracic surgery and trauma at Cedars-Sinai, and his colleagues at Cedars-Sinai, however, use a minimally invasive approach in 89% of their cases.

Video-assisted thoracoscopic surgery (VATS) requires only several small incisions through which instruments and a thoracoscope are inserted. A camera lens at the tip of the scope feeds high-resolution images to a video monitor, giving the surgeon a detailed, magnified view.

"Our study shows that we can do a standard, complete lung cancer surgery in people over 80 with very low risk and good success so that older patients with lung cancer do not have to suffer the consequences of widespread cancer,” said Dr. McKenna, who led the study.

The average 80-year-old can expect to live another 8.6 years, but the average life expectancy of a patient with untreated or palliated early-stage NSCLC is only 1.5 years.

"We have been doing minimally invasive lung cancer surgery for a long time and have the largest experience in the world,” Dr. McKenna added. Dr. McKenna is a pioneer in the development and use of the technology.



Related Links:
Cedars-Sinai Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.